Order Article Reprints

Henson C, Clayburgh D, Lee A, Wong D, Kudrimoti M, Lee S, Kalman N, Rao K, Sohn KY, Crawford J, et al. A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck. Cancers. 2025; 17(10):1663. https://doi.org/10.3390/cancers17101663

Henson, Christina, Daniel Clayburgh, Arielle Lee, Deborah Wong, Mahesh Kudrimoti, Steve Lee, Noah Kalman, Krishna Rao, Ki Young Sohn, Jeffrey Crawford, and et al. 2025. "A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck" Cancers 17, no. 10: 1663. https://doi.org/10.3390/cancers17101663

Henson, C., Clayburgh, D., Lee, A., Wong, D., Kudrimoti, M., Lee, S., Kalman, N., Rao, K., Sohn, K. Y., Crawford, J., Villa, A., & Sonis, S. (2025). A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck. Cancers, 17(10), 1663. https://doi.org/10.3390/cancers17101663